01iBio, Inc. will report Q1 2026 earnings on November 11, 2026 after market close with expected EPS of -$0.07 versus -$0.00 last year.
02The company's stock trades at $0.78 with a $39.7M market capitalization and expects Q1 revenue of $16.7K, up from the prior year.
03iBio has reported negative earnings for at least four consecutive quarters, ranging from -$0.06 to -$0.09 per share.
04Revenue growth and margin trends will be more meaningful indicators than the headline EPS figure for assessing the company's performance trajectory.
Earnings Results
iBio, Inc. (NASDAQ:IBIO) is scheduled to report its Q1 earnings results on November 11, 2026 after market close.
Analysts expect the Healthcare company to report earnings per share of $-0.07, below the $0.00 reported in the same quarter last year. Revenue is expected to come in at $16.7K, up from a year ago.
Company Overview
The stock currently trades at $0.78 with a market capitalization of $39.7M.
Ahead of iBio, Inc.'s earnings report, investors are watching several key metrics beyond the headline EPS number. Revenue growth, margin trends, and forward guidance will likely carry more weight than a single quarter's earnings figure in determining the stock's direction after the report.
Earnings reports are most useful when viewed as part of a trend rather than in isolation. Investors tracking iBio, Inc. should compare this quarter's results against both year-over-year figures and sequential performance to identify whether the business is accelerating, stabilizing, or decelerating. The earnings calendar on Smart Investors Daily tracks upcoming report dates across all publicly traded companies.